In vitro studies demonstrated that a dominant-negative mutant of FAK (impairing the Tyr397 FAK phosphorylation) reduced the ability of gastric cancer cells to migrate, invade, and proliferate when compared with cells overexpressing wild-type FAK [139]. This evidence concerns the gene PTK2 and gastric cancer.